July 3, 2025 · Form 4 insider transaction
Moukheibir Catherine bought 23,500 shares of MOONLAKE THERAPEUTICS at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.